Download Pediatric Neoplasia: Advances in Molecular Pathology and by Navin Pinto MD, Kenan Onel MD, PhD (auth.), Alexander Craig PDF

By Navin Pinto MD, Kenan Onel MD, PhD (auth.), Alexander Craig Mackinnon Jr (eds.)

Pediatric Neoplasia: Advances in Molecular Pathology and Translational Medicine provides the various significant, suitable advances in molecular pathology which are taking place within the box of pediatric oncology and may function an invaluable evaluate for resident and attending physicians in addition to scientists attracted to figuring out the molecular pathology of pediatric melanoma within the context of medical drugs. Chapters are established upon organ structures, and every is written by way of a professional or pair of specialists of their box with subspecialty education and vast medical adventure. each one bankruptcy describes a variable variety of tumors and contains an summary of the type process and clinicopathological features of every tumor. this is often by way of a dialogue of the molecular pathology appropriate to a particular tumor, together with particular molecular markers of the tumors, equipment used for prognosis or scientific administration, scientific value of the markers, and if applicable, an outline or dialogue of present actions in translational learn or matters that must be addressed sooner or later. Pediatric Neoplasia: Advances in Molecular Pathology and Translational Medicine can be of significant price to pathologists, oncologists, hematologists, inner drugs and pediatric experts, in addition to pharmaceutical execs and translational and scientific researchers.

Show description

Read or Download Pediatric Neoplasia: Advances in Molecular Pathology and Translational Medicine PDF

Similar pathology books

Forensic Psychology For Dummies

Taking into account a profession that indulges your CSI fantasies? are looking to comprehend the psychology of crime? even if learning it for the 1st time or an spectator, Forensic Psychology For Dummies delivers all of the necessities for figuring out this fascinating box, complemented with attention-grabbing case examples from all over the world.

Cardiac Tumor Pathology

Cardiac tumors have been as soon as a nosographic entity of scarce medical curiosity due to the rarity and of the intrinsic diagnostic and healing impossibilities, and have been thought of a deadly morbid entity. It has now develop into a topical topic because of advances in medical imaging (echo, magnetic resonance, computed tomography) in addition to innovation in applied sciences of in-vivo prognosis.

The Pathology of the Endocrine Pancreas in Diabetes

Diabetes mellitus represents essentially the most widespread and severe medical syn­ dromes in modern medication. because the finish of the 19th century, the endocrine pancreas has been implicated within the pathogenesis of this affliction. numerous pathologists of the 20th century detected quite a few lesions and mor­ phologic adjustments within the pancreatic islets of diabetic sufferers, however the patho­ physiologic foundation in their findings remained lengthy imprecise.

Additional info for Pediatric Neoplasia: Advances in Molecular Pathology and Translational Medicine

Sample text

Oncology of infancy and childhood. 1st ed. Philadelphia: Saunders, Elsevier; 2009. p. 298. 10. Majhail NS, Lichtin AE. Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med. 2004;71(8):633–7. 11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33(4):451–8. 12. Brunning RD. Classification of acute leukemias.

2). Genetic Abnormalities ALL is genetically heterogeneous. Multivariate analyses in several large clinical studies have clearly established that genetic abnormalities are the most important determinants of response to chemotherapy and outcome in precursor B-ALL [34–43]. Their relevance is likely to increase as targeted therapies are introduced. The genetic abnormalities, which currently have the most significant impact on treatment and management, are t(9;22)(q34;q11)/BCR-ABL1, t(4;11)(q21;q23)/MLL- AFF1, and near haploid/low hypodiploidy, all of which are poor prognostic markers, and to a lesser extent, t(12;21)(p13;q22)/ETV6- RUNX1 and high hyperdiploidy that are favorable prognostic markers [39, 41, 44–46].

4a, b). The t(4;11) demonstrates an age-dependent distribution, and is observed in 50–70% of infant ALL and roughly 5% of pediatric and adult cases. Clinically it is associated with high-risk ALL. Most patients have a CD10−, CD19+ (pro-B) profile with co-expression of myeloid antigens. Breakpoints on MLL gene are dispersed over a wide region, and clustered differently in infant vs. other patients. To date, 104 translocation partners are known of which 64 have been molecularly characterized [69].

Download PDF sample

Rated 4.16 of 5 – based on 4 votes